Click on a filter below to refine your search. Remove a filter to broaden your search.
Increases were seen in both advance directives and end-of-life conversations for patients with advanced cancer.
Risk reduction surgeries before age 50 years substantially cut later cancer risk for those with genetic risk.
The risk for cancer, specifically ovarian cancer, increased with each 10% increment in UPF consumption.
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.
The rate of all-sites cancer incidence was 28.6% lower than expected during the height of the COVID-19 pandemic response.
Older age, white race, and higher education were patient factors associated with initial active surveillance uptake in an unadjusted analysis.
At 30 days after discharge, the mortality rate was 3.2% and skilled nursing facility use rate was 2.6%.
Less of an increase was reported in detection of low-grade localized tumors in statin users versus nonusers.
These preexisting conditions affect functional impairment, mobility and falls.
Total serious harms were extrapolated to affect 795,000 in the US, with 15 dangerous diseases accounting for half of the serious harms.